Intervention

Tiotropium + Olodaterol

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5
Recruiting0
Common conditions2
Lead sponsors shown2
Advertisement

Clinical trials

5 shown
A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA TreatmentNCT04011475 · 2019-12-29
COMPLETED
Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPDNCT03425617 · 2017-01-01
COMPLETED
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD PatientsNCT01533922 · 2012-03-01
COMPLETED
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.NCT01533935 · 2012-02-01
COMPLETED
Japan Long-term Safety for Tiotropium Plus OlodaterolNCT01536262 · 2012-02-01
COMPLETED

Trial status mix

COMPLETED5

Phase mix

PHASE33
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.